68W-32371-04459
2 vaccinations
2 coded responses
16 check-ins
2 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 531 / WI
- Registered
- 2022-10-01
- Relationship
- Child or adolescent in my care
- Guardian
- B2R-23264-26974
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-09-30
Dose 1 — ModernaCo-administered: Hepatitis B:Other:Rotavirus:Tetanus
-
2022-10-01
Registered in v-safe
-
2022-10-01
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-10-02
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Fever · Sleepiness, Irritability/crying, Loss of appetite, DiarrheaUnder 3 check-in
- 2022-10-03
- 2022-10-04
- 2022-10-06
- 2022-10-07
- 2022-10-14
- 2022-10-21
-
2022-10-28
Dose 2 — ModernaCo-administered: Flu
- 2022-11-04
-
2022-11-11
Survey response — day 14, dose 2, under 3MedDRA: Office visit, Respiratory syncytial virus infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Diagnosed with RSV · Healthcare visit (other): Visit at our pediatrician's officeMedDRA releases: 2024-11 · check-in free text available
-
2022-11-11
Report sent to call center — day 14, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-11-14
-
2022-11-14
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-11-18
- 2022-11-25
- 2022-12-02
-
2022-12-09
Survey response — day 42, dose 2, under 3MedDRA: Office visit, Sinusitis — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Sinus infection · Healthcare visit (other): Regular pediatrician appointmentMedDRA releases: 2024-11 · check-in free text available
-
2022-12-09
Report sent to call center — day 42, dose 2, under 3Get care from a doctor or other healthcare professional1 call case(s)
-
2022-12-12
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-01-29
- 2023-04-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-09-30 | Moderna | Hepatitis B:Other:Rotavirus:Tetanus |
| 2 | 2022-10-28 | Moderna | Flu |
Call center
2 call center cases
2 successful
Free text
Release 12 (Under 3) — day 14, dose 2, under 3
Symptoms: Diagnosed with RSV
Healthcare visit (other): Visit at our pediatrician's office
Release 12 (Under 3) — day 42, dose 2, under 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release